Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and Molecular Docking Studies.

The research explores the synthesis of a series of novel hybrid quinazolin-2,4-dione analogs bearing acetyl/amide bridged-nitrogen heterocyclic moieties such as azetidinone, pyrrole, oxazole, oxadiazole, thiazole, pyrazole, and thiazolidine scaffolds . The newly synthesized compounds were structurally confirmed by means of IR, H-NMR, C-NMR, MS and elemental analysis. In addition, an molecular docking analysis of new compounds and standard drug (Chloroquine) has been performed to analyze the binding modes of interaction to the putative active site of Dihydroorotate dehydrogenase (DHODH).

Synthesis, Characterization, Antibacterial Activity, and Computer-Aided Design of Novel Quinazolin-2,4-dione Derivatives as Potential Inhibitors Against .

Cholera is a bacterial disease featured by dehydration and severe diarrhea. It is mainly caused by alimentary infection with . Due to the wide applicability of quinazolin-2,4-dione compounds in medicinal and pharmaceutical chemistry, a new series of -containing heterocyclic compounds was synthesized.

Identification of Novel Antagonists for Rab38 Protein by Homology Modeling and Virtual Screening.

Background: The Rab family proteins are involved in membrane trafficking, cell growth and differentiation. Rab38 is implicated in the biogenesis of melanosomes that help in the synthesis, storage and transport of melanin pigments. The Rab38 protein is overexpressed at the RNA level in melanoma cancer.

Design of novel lead molecules against RhoG protein as cancer target - a computational study.

Cancer is a class of diseases characterized by uncontrolled cell growth. Every year more than 2 million people are affected by the disease. Rho family proteins are actively involved in cytoskeleton regulation.